GSK worldwide
For US residents
GSK Q2 2012 results
Wednesday 25 July
Announcement of results for Q2 2012.
Our commitment to fighting malaria
The impossible is what inspires great science. Dr Joe Cohen, consultant to our Malaria Vaccine Project, talks about his 30 year quest to develop a vaccine against this deadly disease.
Corporate press releases
These press releases are intended for business journalists
and analysts/investors.
13 September 2012
GSK to acquire five million shares in Response Genetics for US$1.10 per share in cash
24 August 2012
GSK and Theravance announce completion of the Phase III programme for once-daily LAMA/LABA (UMEC/VI) in COPD
23 August 2012
GSK announces start of Phase III programme of sirukumab in rheumatoid arthritis
Press release archive
Investors
LSE
1,418p
-22.00
14 Sep 2012 04:35 pm BST
NYSE
45.90
-0.80
14 Sep 2012 04:05 pm EDT